key: cord-0968739-0sk50d55 authors: Morciano, M.; Stokes, J. M.; Kontopantelis, E.; Hall, I.; Turner, A. J. title: Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study date: 2020-11-13 journal: nan DOI: 10.1101/2020.11.11.20229815 sha: c0ef26367cd79a5c9cc211049ef5f6ca242b7b17 doc_id: 968739 cord_uid: 0sk50d55 Background: To estimate excess mortality for care home residents during the COVID-19 pandemic in England, exploring associations with care home characteristics. Methods: Daily number of deaths in all residential and nursing homes in England notified to the Care Quality Commission (CQC) from 1st January 2017 to 7th August 2020. Care home level data linked with CQC care home register to identify homes characteristics: client type (over 65s/children and adults), ownership status (for-profit/not-for-profit; branded/independent), and size (small/medium/large). Excess deaths computed as the difference between observed and predicted deaths using local authority fixed-effect Poisson regressions on pre-pandemic data. Fixed-effect logistic regressions were used to model odds of experiencing COVID-19 suspected/confirmed deaths. Findings: Up to 7th August 2020 there were 29,542 (95%CI: 25,176 to 33,908) excess deaths in all care homes. Excess deaths represented 6.5% (95%CI: 5.5% to 7.4%) of all care home beds, higher in nursing (8.4%) than residential (4.6%) homes. 64.7% (95%CI: 56.4% to 76.0%) of the excess deaths were confirmed/suspected COVID-19. Almost all excess deaths were recorded in the quarter (27.4%) of homes with any COVID-19 fatalities. The odds of experiencing COVID-19 attributable deaths were higher in homes providing nursing services (OR: 1.8, 95%CI: 1.6 to 2.0); to older people and/or with dementia (OR: 5.5, 95%CI: 4.4 to 6.8); among larger (vs. small) homes (OR: 13.3, 95%CI: 11.5 to 15.4); belonging to a large provider/brand (OR: 1.2, 95%CI: 1.1 to 1.3). There was no significant association with for-profit status of providers. Interpretation: To limit excess mortality, policy should be targeted at care homes to minimise the risk of ingress of disease and limit subsequent transmission. Our findings provide specific characteristic targets for further research on mechanisms and policy priority. Larger homes are likely to experience higher footfall in general, and so higher probability of contact with an infected individual, which is likely a contributing factor to the association. Furthermore, it might be easier to ensure person-centred protocols in small care homes due to the scale. There is an urgent need for further research to explore the mechanisms in relation to care home characteristics. Also, to empirically test effective interventions, in consideration of additional impacts on quality of life and psychological wellbeing. However, until this is possible, prioritising existing resources, such as testing and PPE equipment, for care homes to prevent ingress of disease is key to preventing large excess mortality. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.11.20229815 doi: medRxiv preprint ABSTRACT: Background: To estimate excess mortality for care home residents during the COVID-19 pandemic in England, exploring associations with care home characteristics. Methods: Daily number of deaths in all residential and nursing homes in England notified to the Care Quality Commission (CQC) from 1 st January 2017 to 7 th August 2020. Care home level data linked with CQC care home register to identify homes characteristics: client type (over 65s/children and adults), ownership status (for-profit/not-for-profit; branded/independent), and size (small/medium/large). Excess deaths computed as the difference between observed and predicted deaths using local authority fixed-effect Poisson regressions on pre-pandemic data. Fixed-effect logistic regressions were used to model odds of experiencing COVID-19 suspected/confirmed deaths. Findings: Up to 7 th August 2020 there were 29,542 (95%CI: 25,176 to 33,908) excess deaths in all care homes. Excess deaths represented 6.5% (95%CI: 5.5% to 7.4%) of all care home beds, higher in nursing (8.4%) than residential (4.6%) homes. 64.7% (95%CI: 56.4% to 76.0%) of the excess deaths were confirmed/suspected COVID-19. Almost all excess deaths were recorded in the quarter (27.4%) of homes with any COVID-19 fatalities. The odds of experiencing COVID-19 attributable deaths were higher in homes providing nursing services (OR: 1.8, 95%CI: 1.6 to 2.0); to older people and/or with dementia (OR: 5.5, 95%CI: 4.4 to 6.8); among larger (vs. small) homes (OR: 13.3, 95%CI: 11.5 to 15.4); belonging to a large provider/brand (OR: 1.2, 95%CI: 1.1 to 1.3). There was no significant association with for-profit status of providers. Globally, residents in care homes have experienced disproportionately high morbidity and mortality from COVID-19. Across Europe, countries adopting more relaxed strategies to tackle the pandemic, such as Sweden, and those adopting severe lockdowns, like Spain and the UK, have both struggled to protect vulnerable persons in care homes. 1, 2 Early international evidence suggests that nearly half of all COVID-19 deaths in five European countries were among care home residents. 2 Directly attributed COVID-19 deaths do not necessarily capture the full impact on mortality, however. 3 Death toll for COVID-19 relies on SARS-CoV-2 testing, with tests particularly supply-constrained in early parts of the pandemic. Indirect fatalities due to non-COVID-19-related causes might also have increased. For example, through increased risks of harm from isolation 4 and possible delayed/cancelled hospital admissions resulting in unintended iatrogenic events and further deaths. Excess deaths, the additional deaths observed in a given period compared to the number usually expected, better capture direct and indirect mortality impacts. The Office for National Statistics (ONS) in England and Wales have reported aggregated excess deaths by place of occurrence. There was approximately a 79% increase in total deaths in care homes in England and Wales from 2 nd March to 12 th June compared to 2015-19. 5,6 These aggregates, however, do not account for care home residents dying in other settings (e.g. hospital), nor provide sufficient information to reflect on the impacts of enacted policies over the period, or to inform new policies for future virus waves. Likely, not all care homes suffered equally from COVID-19. 7 In Canada, for-profit status was associated with the number of residents infected and deaths after an outbreak. 8 Nursing homes with higher nurse-staffing hours per resident were less likely to experience outbreaks across eight US states. 9 In 179 UK care homes, lower infection rates were found in small homes with high staff-to-resident ratios and low bed occupancy rates. 10 Large care homes experienced higher rates of infection in Wales, 11 and in the Lothian region of Scotland excess deaths were concentrated in a minority of care homes with an outbreak. 12 A national breakdown of excess deaths by care home characteristics is largely lacking from the current literature in England. 6 The aim of this study is to use nationally representative administrative data from all care homes in England to quantify the excess mortality for residents during the first 23-weeks of the COVID-19 outbreak, and to explore associations with care home characteristics. We then use multivariable logistic regression to estimate the odds of care homes experiencing a suspected or confirmed COVID-19 death across care home types. This knowledge might inform a targeted policy response in future waves. The English care home market is mostly private and very fragmented, with the type of service provided, client type(s) covered and bed capacity varying systematically by provider-type and the local authorities in which they operate. 13 There are two main categories of care homes: care homes providing nursing services and those which do not. Care homes which do provide nursing services (nursing homes) cater for people who have complex clinical needs that require regular attention from registered nurses. Care homes which do not offer nursing care (referred to as residential homes) cater for people who often require personal care only, with district nurses and physicians called in when necessary. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.11.20229815 doi: medRxiv preprint Further differences in care homes' organisational characteristics and operational strategies (for-profit/not-for-profit, independent or belonging to a corporate chain/groups of providers(branded), small/medium/large) might also influence the ability of care homes to put in place effective infection, prevention and control protocols. For example, advanced care planning to ensure patient-centred management, ability to access Personal Protective Equipment (PPE),SARS-CoV-2 testing capacity constraints, as well as staff-to-resident ratios and policies on staff and patient movement across facilities. 14 Policies adopted in the wider health and care system might have also impacted COVID-19 infections in English care homes. In mid-March, Hospital Trusts discharged medically fit patients to care homes to free capacity. 15 Mandatory testing prior to discharge was only brought into effect a month later. 16, 17 On March 24 th the wider population were ordered not to leave their home except for "essential" reasons, 18 including visiting care homes, later clarified to only in exceptional circumstances. Care home-level daily death notification data sent by registered care home operators in England in the period 1 st of January 2017 to 7 th August 2020 to the Care Quality Commission (CQC), the independent regulator of health and adult social care in England. All providers must send their notifications to CQC without delay. 19 The data includes all deaths of care home residents regardless of whether they occurred in care homes or elsewhere (e.g. in hospital). 20 From 10 th April 2020, deaths suspected (based on the statement of care home providers) or confirmed (tested) to be attributable to COVID-19 (COVID-19 deaths) were also identified. 21 All other deaths are classified as non-COVID-19 deaths. Death notification data were linked at a care home-level with CQC registers of active care homes in England, providing data on care home characteristics: setting type (nursing or residential home), client types (offering services for people aged 65+ and/or people with dementia or offering services to children and adults), ownership status (whether not-for-profit -charity/NHS/local-authority-run homes -or for-profit), whether known to CQC to be independent or affiliated to a large provider/brand, and their registered maximum bed capacity (coded as small (less than 23 beds), medium (24-40 beds) and large (41 or more beds)). Providers enter and leave the market over time. In January 2017, there were 16,481 active care homes, reducing to 15,554 by January 2020. Bed capacity is more stable, with 460,323 beds in January 2017 and 457,347 in January 2020. For the calculation of excess deaths, we use data from the 13,630 care homes which reported at least one death over the study period. 32 (0.17%) care homes were excluded from the analysis due to inability to match with CQC registers. Of all 19,271 care homes reported to be active at some point between 1 st of January 2017 and 7 th August 2020, 3,747 care homes were no longer active in March 2020, meaning . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.11.20229815 doi: medRxiv preprint 15,524 care home were used when modelling the odds of experiencing any COVID-19 fatalities. To calculate excess deaths, we aggregated daily care home-level deaths to weekly and local authority level. This aimed to reduce the incidence of zeros and the nonconstant intra-week variation in death counts (Appendix 1,p.1). Therefore, excess deaths were estimated using aggregated data for 150 local authorities for a period of 188 weeks: 165 weeks (1 January 2017-3 March 2020) as the pre-COVID-19 period and 23 weeks (4 March 2020 -7 August 2020) as the post-COVID-19 period, with the start of the COVID-19 period defined by the first week in which one COVID-19 death was reported in England. 22 To calculate excess deaths overall and by care home characteristics, we first used data from the pre-COVID-19 period to estimate expected death trends. 23 After comparing predictive accuracy with more complex models structures (Appendix 2,p.3), a Poisson regression model (standard log link) was selected, with covariates including a quartic polynomial of week-of-the-year (to account for seasonality) and local authority fixed effects (to account for determinants of deaths that differ across local authorities but do not change over time). Predicted weekly deaths for each local authority were used as the estimated counterfactual in the COVID-19 period (i.e. the deaths that would have occurred in the absence of the pandemic). National excess deaths were computed as the sum of the difference between observed and counterfactual deaths over all local authority-weeks. Excess deaths per hundred bed capacity (excess deaths per bed) were also reported. 95% confidence intervals were constructed by bootstrapping with local authority resampling (50 replications). We also report observed weekly deaths flagged as confirmed or suspected COVID-19 fatalities to show the proportion of excess deaths directly attributed to COVID. The timing and pattern of excess deaths were likely to vary considerably according to whether a care home has experienced an outbreak or not. As nationwide care home-level data on COVID-19 outbreaks are collated but not publicly available, 24 we classified care homes according to whether a confirmed/suspected COVID-19 death had been reported in the 23-week COVID-19 period. We used multivariable logistic regression with local-authority fixed effects (controlling for all time-invariant determinants of disease spread at the area level) to estimate unadjusted and adjusted odds of reporting any COVID-19 fatalities on covariates. All analyses were performed in StataMP v14ยท2. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all of the data and the final responsibility to submit for publication. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; Table 1 summarises the characteristics of all care homes in England active in March 2020. The minority (4,428, 28.5%) provided nursing services. However, on average nursing homes had more beds than residential homes (50.6 beds versus 20.9) since they are larger (60.2% versus 12.9% with 41+ beds). This explains the more comparable supply of total beds in nursing (223,917) and residential care homes (231,677). Almost all (93.4%) nursing homes in England provided services to older people and/or people with dementia, as well as the majority (63.1%) of residential homes. Over a third (37.7%) of care homes were affiliated to a larger branded provider/chain. The proportion of branded care homes was higher (45.8%) for nursing care homes than for residential homes (34.5%). 90.5% of nursing homes were for-profit, with slightly less (83.3%) residential homes. Overall, approximately 6 in 10 care homes experienced at least one death in the COVID-19 period, with a larger share of nursing homes (89%) reporting fatalities than residential homes (47.9%). 5,641 care homes were active at some point in the study period but did not report fatalities. These were mainly small residential homes, with an average bed capacity of 9.21 (95% CI: 8.95 to 9.49). 27.4% of care homes reported COVID-19 confirmed/suspected fatalities, most in nursing (54.2%) rather than residential homes (16.7%). [ Table 1 here] Prior to the COVID-19 period, predicted deaths tracked observed deaths relatively closely (Appendix 3, p.9). During the COVID-19 period, observed deaths were considerably higher than predicted from historical trends (Figure 1 ). Most excess deaths occurred during the 10 weeks between 25 th March and 2 nd June. At the end of the study period, excess deaths were lower than predicted, especially in nursing homes. Overall, 64.7% of calculated excess deaths (95% CI: 56.4% to 76.0%) were reported to be attributable to confirmed/suspected COVID-19, with this proportion increasing over time. [ Figure 1 here] . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.11.20229815 doi: medRxiv preprint There were 29,542 (95% CI: 25,176 to 33,908) excess deaths in all care homes over the COVID-19 period ( Excess deaths were significantly higher in facilities that provided services to older people and people with dementia, mainly for nursing homes, with excess deaths per bed of 8.6% (95% CI: 7.3% to 9.9%). For-profit and not-for-profit nursing homes had comparable excess deaths per bed, but the rate was nearly double in not-for-profit residential homes (7.7% versus 4.1%). Branded homes experienced higher excess deaths per bed than independent care homes (7.2% versus 5.8%). This difference largely occurred among residential homes (5.6% versus 4%). Larger care homes also had higher excess deaths per bed (8.6% versus 2.2% in small homes). The starkest difference in excess deaths was between care homes that experienced and did not experience at least one suspected/confirmed COVID-19 death, with the former responsible for almost all excess deaths (29,429, 95% CI: 25,047 to 33,810). For graphical inspection see Appendix 4,p.12. For homes experiencing COVID-19 attributable fatalities, excess deaths per bed were comparable across settings (13.8% nursing; 13.0% residential). Estimated excess deaths for nursing homes not reporting COVID-19 deaths were negative (-831, 95% CI: -1,291 to -371), corresponding to an estimated excess deaths per bed of -1% (95% CI: -1.6% to -0.5%). On the other hand, there were 943 excess deaths (95% CI: 503 to 1,383) in residential homes not reporting COVID-19 deaths, corresponding to an excess deaths per bed of 0.6% (95% CI: 0.3% to 0.9%). [ Table 2 here] After adjusting for other care home characteristics, nursing homes had a statistically significant higher odds of experiencing COVID-19 confirmed/suspected deaths than residential homes (OR: 1.8, 95% CI: 1.6 to 2.0) ( Table 3) . Care homes offering services to older people and/or people with dementia were particularly exposed (OR: 5.5, 95% CI: 4.4 to 6.8). Branded care homes experienced significantly higher odds of one COVID-19-related death compared to independent homes (OR: 1.2, 95% CI: . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; 1 0 1.1 to 1.3), although not-for-Profit and for-profit homes experienced roughly equal odds of one COVID-19 death (overall OR: 1.0, 95% CI: 0.8 to 1.1). Compared to small care homes, medium-sized facilities experienced higher odds of COVID-19related deaths (OR: 5.2, 95% CI: 4.5 to 6.0), with large-sized homes experienced even greater odds (OR: 13.3, 95% CI: 11.5 to 15.4). Results were robust to controlling for deprivation and urbanicity of the care home location, and to restricting the sample to care homes providing services to older people/with dementia (Appendix 5, p.14). [ Table 3 here] Using provider-level administrative data on all care homes in England, we estimated that there were over 29,500 excess deaths of care home residents during the first 23-weeks of COVID-19, equivalent to 6.5% of all care home beds. Almost 65% of the excess deaths were reported to be directly attributable (confirmed/suspected) to COVID-19. Our analysis shows that almost all excess deaths were recorded in the quarter of care homes which reported COVID-19 fatalities. This highlights that: (i) non-COVID-19 attributed excess deaths were likely to be directly due to COVID-19; and/or (ii) any indirect negative effects of COVID-19 and enacted policies on mortality were predominantly constrained to those homes experiencing an outbreak. Non-COVID-19 attributed deaths being reported mainly during the early stages of the pandemic, when CQC recording of COVID-19 death was missing (before 10 th April), guidance focused on a narrower set of symptoms and there was a shortage of testing, providing support for the former hypothesis. Excess deaths were mainly concentrated among large and branded homes that provide services to older people and people with dementia. Adjusted care home level analysis confirmed these findings. To our knowledge, this is the first independent analysis that uses national administrative records from all care homes in England to estimate the impact of COVID-19. We find comparable total deaths to official estimates, 5 adding stratifications of excess deaths by key care home characteristics and multivariable analysis to add a more nuanced understanding of these deaths. Local-authority fixed effects were used to account for time-invariant measured and unmeasured determinants and confounders that differ across local authority. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; Our study also has limitations. Firstly, we can observe the counts of COVID-19 attributed fatalities across care homes but not whether non-fatal COVID-19 cases occurred. This case data is not available, though serological and whole genome sequencing studies give insights to this. 24 The attribution of COVID-19-related deaths is based on statements from providers to the CQC starting from 10 th April 2020 and not always testing-confirmed or reflected in the death certificate. COVID-19 attributable deaths occurred before the 10 th April would have been miscoded. The reported lower rates of testing could lead to some relevant deaths not having COVID-19 listed as a contributory factor, leading to apparently higher non-COVID-19 excess deaths. 5, 10, 21 No data was available on occupancy rates at care home level. We instead used maximum bed capacity as reported in March 2020, assuming full occupancy. In the UK, occupancy rates were estimated to be on average 90% in nursing homes and 91% in residential homes. 13 It is very likely that occupancy rates declined during the COVID-19 period. However, assuming an arbitrary lower occupancy would increase excess mortality rates only proportionally, unless further breakdowns by time and care home types became available. Measures of staffing and working conditions, residents' case mix and their sociodemographic status, and individual care home shortages of equipment would have been relevant for this analysis but there is no national care-home level data available. Our analysis is instead based on providers' characteristics as reported to CQC. We did not account for exposure and incidence of COVID-19 in the local area where each care home is located, or local policy responses to the pandemic, which changed over time. Wider community testing was negligible in the early parts of our analysis period, 25 and likely differed by local authority capacity which would bias results if included. Good quality data on local policy responses was also unavailable. Finally, as the number of deaths in the absence of the outbreak cannot be observed but only predicted, there is the potential that market dynamics and prediction errors could influence excess deaths estimates. However, we estimated small prediction errors in the pre-COVID-19 period relative to the size of excess deaths in the COVID period. Excess death estimates were also robust to different modelling approaches. By comparing observed deaths against averages over historical 5-year period, the ONS estimated 25,876 excess deaths in English care homes up to August 8 th . 5 Our estimates exceed this slightly. In addition to differences in methods, this is likely due to our data including deaths of care home residents occurring outside of a care home setting (e.g. in hospital). Consistent with previous studies, we find that excess deaths occur overwhelmingly in the minority of care homes that experience COVID-19 fatalities. 12 This might suggest . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.11.20229815 doi: medRxiv preprint higher proportions of COVID-19-related excess deaths than reported, 26 and that some death are potentially avoidable if initial care home outbreaks had been prevented. However, our results suggest that other care homes characteristics, relating to type of residents, staffing, ownership and size, are also important. Care homes providing services to older people/with dementia suffered most deaths. This is unsurprising given the increased risk of contracting SARS-CoV-2 (difficulties complying with physical distancing, masking and hand hygiene) and increased risk of morbidity/mortality (comorbid illnesses), frailty and age. However, for care homes serving this group, there were smaller odds of COVID-19-related deaths in nursing compared with residential care homes. This might suggest a protective effect of the presence of staff with nursing backgrounds and infection, prevention and control (IPC) training, as found in other settings. 9 Overall, though, nursing homes had the most excess deaths and odds of COVID-19 confirmed/suspected deaths. This is likely due to these homes containing residents at high risk of contracting and dying of SARS-CoV-2, increased frailty and higher prevalence of co-morbidities, and therefore a greater likelihood of being in contact with other healthcare settings and practitioners. 27 In line with the existing literature, we found that large care homes are more likely to experience negative outcomes. [10] [11] [12] A likely contributor is that larger homes have a higher footfall altogether, of staff, healthcare workers, residents flowing in and out of hospitals, and visitors in non-pandemic times. This increases their chances of exposure to an infected individual, particularly in the absence of rigorous testing. Furthermore, it might be easier to ensure patient-centred management protocols in small care homes where policies around staff and patients contacts are set for smaller scales. 28 We find no significant differences between for-profit and non-for-profit providers, although for-profit providers experienced the most excess deaths because they account for the majority of the market. A Canadian study showed for-profit status was not associated with the odds of an outbreak, although it was associated with the extent of an outbreak (number of cases and deaths). 8 However, we find that branded care homes had greater odds of COVID-19 confirmed/suspected deaths and rates of excess deaths. Branded homes could have policies around staff and patient movement across facilities that could aid the spread of infection. 7 Specialist initiatives are needed for patients/staff/visitors to minimise the risk of initial infection in care homes. What prevention policies are optimal (e.g. PCR testing, staff cohorting, visitor restrictions, hospital discharge policies, limiting visiting professionals, tracing staff etc.) 29 requires further research and dialog with operators and public health experts. Their efficacy depends upon the care home setting in which they are implemented and the behavioural responses of residents and staff. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.11.20229815 doi: medRxiv preprint Critically, any benefits from such policies would need to be weighed against costs and potential adverse outcomes, such as reduced quality-of-life or psychological well-being. 29, 30 There is an urgent need for further research to explore the mechanisms hypothesized above in more detail. Evaluations of alternative interventions are required. However, our results suggest that until this is possible, prioritising existing resources, such as testing and PPE equipment, to prevent initial infections in care homes is key to preventing large excess mortality. The authors declare that they have no competing interests. Contributors: MM did the econometric analysis, and led the design and the writing of the paper. JS and AJT contributed to the design, the econometric analysis, interpretation of findings and the writing of the paper. IA oversaw the econometric analysis, supported the data acquisition, contributed to the design, interpretation of findings and the writing of the paper. EK advised on the design and contributed to the writing of the paper. AJT and IH verified the underlying data. The authors are grateful to the DH&SC, CQC and the members of the Care Home Working Group for their suggestions in all phases of the research. Data Availability: Care home-level daily death notification data provided by the Care Quality Commission (CQC) and linked with CQC registers of active care homes in England. Data Neither the funders nor the collectors/curators/delivers of the data bears any responsibility for the analyses or interpretations presented here. Data can be requested to the CQC. The statistical code is available from the corresponding author. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted November 13, 2020. ; The invisible pandemic Mortality associated with COVID-19 outbreaks in care homes: international evidence. Article in LTCcovid.org, International Long-Term Care Policy Network 2020 Detrimental effects of confinement and isolation in the cognitive and psychological health of people living with dementia during COVID-19: emerging evidence. Article in LTCcovid.org, International Long-Term Care Policy Network 2020 Deaths involving COVID-19 in the care sector, England and Wales: deaths occurring up to 12 Article in LTCcovid.org, International Long-Term Care Policy Network, CPEC-LSE An Infection Prevention and Control perspective on why COVID-19 has had such a deadly impact on care home residents in the UK. LTCcovid.org, International Long-Term Care Policy Network For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths Association of Nursing Home Ratings on Health Inspections, Quality of Care, and Nurse Staffing With COVID-19 Cases Covid-19 infection and attributable mortality in UK Long Term Care Facilities: Cohort study using active surveillance and electronic records Risk factors for outbreaks of COVID-19 in care homes following hospital discharge: a national cohort analysis Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK. The Lancet Healthy Longevity Competition Markets Authority. Care homes market study Preventing more deaths in care homes in a second pandemic surge Important and Urgent -Next steps on NHS response to COVID-19 Department of Health & Social Care. COVID-19: our action plan for adult social care Health Secretary gives update on new 'lockdown' measures announced to tackle coronavirus Notification of death or unauthorised absence of a service user who is detained or liable to be detained under the Mental Health Act Inclusion of CQC data in ONS deaths reporting shows impact of COVID-19 on social care Publication of statistics on deaths involving COVID-19 in care homes in England: transparency statement Chief Medical Officer (CMO) Professor Chris Whitty statement on first death of patient with coronavirus (COVID-19) Excess mortality in England and Wales during the first wave of the COVID-19 pandemic Briefing: Adult social care and COVID-19. Assessing the impact on social care users and staff in England so far: Health Foundation Covid-19: Lack of capacity led to halting of community testing in March, admits deputy chief medical officer High Prevalence of SARS-CoV-2 Antibodies in Care Homes Affected by COVID-19 Centers for Disease Control and Prevention. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States Rapid increase of Care Homes reporting outbreaks a sign of eventual substantial disease burden The impact of COVID-19 measures on well-being of older long-term care facility residents in the Netherlands Panel b) total excess deaths per bed (in %